In vivo CAR-T is not simply ex vivo without a manufacturing step. It is a different modality that relies on biological systems to regulate outcomes.
- Nanotechnology Drug Delivery: A Market Overview
- Combination: The Drug Delivery Word Of The Year For 2026
- In Vivo LNP-Engineered Cytokine-Armored CAR Cells For Solid Tumors
- Electronic Drug Delivery Devices Market: Advancing Smart, Connected Healthcare
- Regulating For Patient Safety And Success With Combination Products
- FDA Issues Final Guidance For pH Adjuster Waiver Requests For Generic Drugs
- Strained Manufacturing, Complexity Stymie In Vivo Progress
- To Fight Cancer, Gene Editing Needs To Solve Its Delivery Problem
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Rational Design Of Oral Nanosuspensions For Insoluble Drugs
The advantages of nanosuspension dosage forms include improving bioavailability and API stability, increasing drug loading, better dose flexibility and accuracy, and easy swallowing for pediatric or geriatric populations.
-
Build A Vial-Stopper Combination Suitable For Drug Product Storage At -80°C
This study worked to determine if the chosen vial-stopper-seal combination will remain integral while frozen at -80°C, under studied conditions, when the appropriate materials, processing, and sealing conditions are applied.
-
PFAS In Medical Devices: Expert Insights On Frequently Asked Questions
Watch to learn more about PFAs in medical devices, covering environmental concerns, health risks, testing, alternatives and management strategies with Shalene Thomas of Battelle.
-
Ready-To-Use Cartridges: Ensuring Compatibility For GLP-1-Based Drugs
Ready-to-use cartridges for GLP-1 applications offer safe, reliable self-administration. See how they can minimize complexities and better align with the stringent demands of modern manufacturing.
-
Navigating PFAS In Medical Devices
Review how an experienced partner can help you navigate the shifting regulatory landscape for your medical device.
-
Delivering Child-Friendly, Broad-Range Dosing For Toddlers
A European-based pharmaceutical company wanted to improve their pancreatic enzyme product (PEP) delivery to patients who have difficulty swallowing several capsules a day – especially children with cystic fibrosis and other conditions.
-
How Nanoparticle Platforms Are Unlocking Genetic Medicine's Potential
Explore how the HIT SCAN platform accelerates gene therapy delivery by screening polymeric nanoparticles, enhancing precision and regulatory pathways for next-generation genetic medicines.
-
Choosing A Formulation And Process Approach To OCR Products
Do you want to develop an oral controlled release (OCR) product? Understand the options and their ramifications as the first step toward devising a plan.
-
Liposome Vs. Lipid Nanoparticle: What's The Difference?
Here, we discuss the differences between nanoparticles and liposomes along with their applications in medicine.
-
Transitioning From Vial To Prefilled Syringe
Understand how formulation development for a prefilled syringe affects manufacturing, driving the industry toward optimizing delivery of injectable products and, ultimately, improving patient care.
TOM'S TAKES ON DRUG DELIVERY
TALKING WITH TOM VIDEOCASTS
DELIVERED BY DEGRAZIO
-
Drug Delivery Trends From 2025: Top 4 For Momentum Gains In 2026
In this article, Fran DeGrazio identifies four notable trends in drug delivery that gained momentum in 2025 and, she predicts, will continue to do so in 2026 and beyond. They are digitalization, sustainability, patient centricity, and the advanced delivery of complex biopharmaceuticals.

